BRIAKINUMAB
UNII 978I8M0P8X

Substance Identification & Data

This profile provides standardized clinical and technical data for Briakinumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 978I8M0P8X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 339308-60-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

978I8M0P8X

CAS Registry Number

339308-60-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRIAKINUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C95321

National Cancer Institute reference terminology for clinical and research data.

INN ID

9153

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-138

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Briakinumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRIAKINUMAB

Common Names & Synonyms

BRIAKINUMAB [INN]

BRIAKINUMAB [USAN]

BRIAKINUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-12 SUBUNIT BETA (IL-12 SUBUNIT P40, CLMF P40 OR NKSF2)); HUMAN MONOCLONAL .GAMMA.1 HEAVY CHAIN (218-216')-DISULFIDE WITH HUMAN MONOCLONAL .GAMMA. LIGHT CHAIN, DIMER (224-224'':227-227'')-BISDISULFIDE